Good disclosure doesn't cure bad accounting-Or does it?. Evaluating the case for SFAS 158.

Cathy Beaudoin, Nandini Chandar, Edward M. Werner

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

This paper investigates whether the newly required recognition of the funded status of defined benefit (DB) plans under SFAS 158 is incrementally value relevant in its adoption year (2006) relative to the corresponding amounts which were previously disclosed from both equity investor and credit rating perspectives. In equity valuation models, we use a sample of 878 firms (1756 firm years) offering DB plans in 2005 (disclosure year) and 2006 (recognition year), and find no incrementally significant association with market prices of newly recognized amounts under SFAS 158 over the same information that was disclosed pre-SFAS 158. Our credit rating tests, using a sample of 428 DB firms (856 firm years) for 2005 and 2006 also show no differential impact of recognition over disclosure. Overall, we find that equity investors price the SFAS 158-imposed pension differential while credit rating agencies do not, regardless of whether such information is recognized or disclosed in the financial statements. Our results are consistent with efficiency in both equity and credit markets with respect to pension information and suggest that SFAS 158 has not changed the way market participants in aggregate use pension-related financial statement information.

Original languageEnglish (US)
Pages (from-to)99-110
Number of pages12
JournalAdvances in Accounting
Volume27
Issue number1
DOIs
StatePublished - Jun 2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Accounting
  • Finance

Keywords

  • Defined benefit plans
  • Disclosure
  • Pension accounting
  • Recognition
  • SFAS 158

Fingerprint

Dive into the research topics of 'Good disclosure doesn't cure bad accounting-Or does it?. Evaluating the case for SFAS 158.'. Together they form a unique fingerprint.

Cite this